476 filings
Page 3 of 24
10-QT
2gb o684oova9
5 Jun 23
Quarterly report for transitional period
4:05pm
8-K
amfxjnm4
22 May 23
Regulation FD Disclosure
7:00am
8-K
zccvfw1u8ke ngjro8
18 May 23
Departure of Directors or Certain Officers
4:05pm
8-K
tof6ke5uog1x7 nm
11 May 23
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
4:20pm
8-K
zgb 2jk1u5s7l5m08
24 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
rm62ao5aoaqg 16
29 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:04pm
UPLOAD
ct51sjfpt yv25ov4a
20 Mar 23
Letter from SEC
12:00am
CORRESP
vfthgfzj3om8f97m
16 Mar 23
Correspondence with SEC
12:00am
UPLOAD
vtl2s rih
8 Mar 23
Letter from SEC
12:00am
S-8
72pyn
6 Mar 23
Registration of securities for employees
4:22pm
8-K
eayslu1eru5wj
14 Feb 23
NeuBase Therapeutics Reports Business Update and Financial Results
4:20pm
424B5
qt16iik
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
gjzvwp5 1az
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm
8-K
fxj3o eb5
21 Dec 22
NeuBase Therapeutics Reports Business Update and Financial Results
8:10am
8-K
oubh2 k996byhzxuee6z
24 Oct 22
Departure of Directors or Certain Officers
4:45pm
8-K
91h5nc sa2ig2
14 Oct 22
NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing
4:20pm
8-K
jii8u6j5hk
3 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:15am